Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-((6S,9S,12R,17R,20S,23S,25aS,31S,34S,37S,40S,43R,45aS,50aS,55R)-31,34-bis(2-amino-2-oxoethyl)-55-(2-aminoacetamido)-17-carbamoyl-9-(hydroxymethyl)-6-isobutyl-37,40-dimethyl-5,8,11,19,22,25,30,33,36,39,42,45,50,56-tetradecaoxo-20-(4-(sulfooxy)benzyl)hexatetracontahydro-1H,5H-12,43-(epiminopropanodithiomethano)tripyrrolo[2,1-e1:2',1'-h1:2'',1''-m][1,2]dithia[5,8,11,14,17,20,23,26,29,32,35,38,41]tridecaazacyclotetratetracontin-23-yl)acetic acid
ID: ALA5178267
PubChem CID: 168277411
Max Phase: Preclinical
Molecular Formula: C65H95N19O25S5
Molecular Weight: 1702.92
Associated Items: